Efficacy of combination therapy of mid-urethral sling and low-dose Abobotulinumtoxin-A injection in mixed urinary incontinence

Efficacy of combination therapy of mid-urethral sling and low-dose Abobotulinumtoxin-A injection in mixed urinary incontinence


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سکینه حاج ابراهیمی , هوشنگ شمسی سیسی , الهام جهان تابی , هانیه صالحی پورمهر

کلمات کلیدی: Abobotulinumtoxin‐A, mixed urinary incontinence, transobturator tape

نشریه: 25284 , 1 , 41 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله هانیه صالحی پورمهر
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات پزشکی مبتنی بر شواهد EBM
کد مقاله 76915
عنوان فارسی مقاله Efficacy of combination therapy of mid-urethral sling and low-dose Abobotulinumtoxin-A injection in mixed urinary incontinence
عنوان لاتین مقاله Efficacy of combination therapy of mid-urethral sling and low-dose Abobotulinumtoxin-A injection in mixed urinary incontinence
ناشر 5
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Objectives: To determine the outcome of combined transobturator tape sling (TOT) and low dose intradetrusor injection of Abobotulinumtoxin‐A (Abobot‐ A, Dysport®) in women with mixed urinary incontinence (MUI). Methods: This randomized, active comparator‐controlled, parallel‐group, two‐part clinical trial was conducted on women who had positive Valsalva leak point pressure (VLPP) + detrusor overactivity (DO), cough‐associated DO. In Part 1, 20 women with MUI who had a failure of medical and behavioral therapies to cure MUI, randomized in two groups receiving TOT surgery alone, or in combination with Dysport® injection (n = 10 in each group), and then Part 2 was initiated as a prospective open‐label on 40 more patients. We performed cystoscopy and injected 300 U of Dysport®in 20–30 intradetrusor injection sites in each patient. Results: The patient's symptoms in both groups decreased significantly after treatment. The symptoms were improved significantly in the combination therapy group according to the International Consultation on Incontinence Questionnaireoveractive bladder (ICIQ‐OAB) questionnaire (p<.001), and International Consultation on Incontinence Questionnaire‐urinary Incontinence‐short form (ICIQUI‐ SF) (p=.041) in comparing with the TOT group. In Part 2, the mean score was 17.10 (4.75) for ICIQ‐UI‐SF and 9.22 (2.89) for ICIQ‐OAB before the treatment. Twelve weeks after the intervention, the median (interquartile range: IQR) of ICIQOAB symptoms (2.0 [3.0]; p <.001) and ICIQ‐UI‐SF decreased, too (1. 0 [2.0]; p <.001). Considering improvement using Patient Global Impression of Improvement scale, 46 (92.0%) stated that they had significant subjective improvement of their symptoms. Conclusions: Combination therapy was accompanied with a promising effect in the patients with MUI according to the results of standardized questionnaires. However, further studies with controlled arms are recommended.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سکینه حاج ابراهیمیاول
هوشنگ شمسی سیسیدوم
الهام جهان تابیسوم
هانیه صالحی پورمهرچهارم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
17207315.pdf1400/07/06997087دانلود